https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-11-01 / Int J Hyperthermia 2002 Nov-Dec;18(6):506-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-11-01 / Int J Hyperthermia 2002 Nov-Dec;18(6):506-202002-11-01 00:00:002019-02-15 08:48:26Cancer immunotherapy: stress proteins and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-10-29 / Cancer Immunol. Immunother. 2002 Dec;51(11-12):663-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-10-29 / Cancer Immunol. Immunother. 2002 Dec;51(11-12):663-82002-10-29 00:00:002019-02-15 08:53:33Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-10-01 / Clin. Exp. Immunol. 2002 Oct;130(1):107-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-10-01 / Clin. Exp. Immunol. 2002 Oct;130(1):107-142002-10-01 00:00:002019-02-15 08:37:56Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B – restoration by exogenous interleukin-12
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-10-01 / Transfus. Apher. Sci. 2002 Oct;27(2):183-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-10-01 / Transfus. Apher. Sci. 2002 Oct;27(2):183-62002-10-01 00:00:002002-10-01 00:00:00Dendritic cells in vaccination therapies of malignant diseases
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-09-01 / Blood 2002 Sep;100(5):1734-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-09-01 / Blood 2002 Sep;100(5):1734-412002-09-01 00:00:002019-02-15 08:44:52Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-09-01 / J. Immunol. 2002 Sep;169(5):2422-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-09-01 / J. Immunol. 2002 Sep;169(5):2422-92002-09-01 00:00:002019-02-15 09:18:08Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-09-01 / Haematologica 2002 Sep;87(9):989-1001
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-09-01 / Haematologica 2002 Sep;87(9):989-10012002-09-01 00:00:002019-02-15 08:51:09Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-09-01 / Am J Otolaryngol 2002 Sep-Oct;23(5):293-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-09-01 / Am J Otolaryngol 2002 Sep-Oct;23(5):293-62002-09-01 00:00:002019-02-15 08:51:32Postirradiation malignant fibrous histiocytoma of the larynx: a case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-08-02 / Dtsch. Med. Wochenschr. 2002 Aug;127(31-32):1660
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-08-02 / Dtsch. Med. Wochenschr. 2002 Aug;127(31-32):16602002-08-02 00:00:002002-08-02 00:00:00[Is total body hyperthermia plus chemotherapy useful in pancreas carcinoma?]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-08-01 / Ann. Oncol. 2002 Aug;13(8):1173-84
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-08-01 / Ann. Oncol. 2002 Aug;13(8):1173-842002-08-01 00:00:002019-02-15 09:17:52Heating the patient: a promising approach?
